Log in | Register

Haloperidol serum concentrations in critically ill patients included in the REDUCE study

Anne W. van Schijndel| Eric J. F. Franssen| Peter Pickkers| Saskia Rijkenberg| Mark van den Boogaard| Peter H. J. van der Voort
Letter
Volume 44, Issue 10 / October , 2018

Pages 1774 - 1775

No abstract available.

References

  1. Van den Boogaard M et al (2018) Effect of haloperidol on survival among critically ill adults with a high risk of delirium: the REDUCE randomized clinical trial. JAMA 319(7):680–690
    • View reference on publisher's website
    • View reference on PubMed
  2. Nederlandse Vereniging van Ziekenhuisapothekers (2006) Therapeutic drug monitoring: haloperidol. http://tdm-monografie.org/Media/Default/Monografieen/TDM%20Haloperidol%20210206.pdf. Accessed 23 Aug 2018.
  3. Chernecky CC, Berger BJ (2007) Laboratory tests and diagnostic procedures. Elsevier, Amsterdam

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement